These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27513347)

  • 21. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
    Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
    BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening and prevention: cervical cancer.
    Weinstein LC; Buchanan EM; Hillson C; Chambers CV
    Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
    Eltabbakh GH; Eltabbakh GD
    J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
    Sawaya GF
    Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
    [No Abstract]   [Full Text] [Related]  

  • 25. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.
    Moreira ED; Oliveira BG; Ferraz FM; Costa S; Costa Filho JO; Karic G
    Int J Gynecol Cancer; 2006; 16(2):599-603. PubMed ID: 16681732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
    Printz C
    Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
    MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
    J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of abnormal cervical cancer screening outcomes among screening-compliant women in the United States.
    Chido-Amajuoyi OG; Shete S
    Am J Obstet Gynecol; 2019 Jul; 221(1):75-77. PubMed ID: 31078510
    [No Abstract]   [Full Text] [Related]  

  • 29. HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.
    Richardson LA; El-Zein M; Ramanakumar AV; Ratnam S; Sangwa-Lugoma G; Longatto-Filho A; Cardoso MA; Coutlée F; Franco EL;
    Cancer Cytopathol; 2015 Dec; 123(12):745-54. PubMed ID: 26230283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do it yourself cervical cancer test: A gateway to increase cervical cancer screening in Pakistan.
    Baig E; Furqan A; Abid M
    J Pak Med Assoc; 2023 Apr; 73(4):955. PubMed ID: 37052033
    [No Abstract]   [Full Text] [Related]  

  • 31. Confusion about Pap smears: lack of knowledge among high-risk women.
    Daley E; Perrin K; Vamos C; Hernandez N; Anstey E; Baker E; Kolar S; Ebbert J
    J Womens Health (Larchmt); 2013 Jan; 22(1):67-74. PubMed ID: 23215902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
    Malo TL; Perkins RB; Lee JH; Vadaparampil ST
    Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical cancer prevention: new guidelines in the United States and new opportunities for low- and middle-income countries.
    Waxman AG
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):251-5. PubMed ID: 23732029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus-related content in state and tribal comprehensive cancer control plans.
    Steele CB; Thomas CN; Richardson LC
    J Womens Health (Larchmt); 2008; 17(1):5-10. PubMed ID: 18240976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States.
    Roland KB; Soman A; Benard VB; Saraiya M
    Am J Obstet Gynecol; 2011 Nov; 205(5):447.e1-8. PubMed ID: 21840492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of and attitudes and knowledge about pap smears among women in Kuwait.
    El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
    J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Pap test: George N. Papanicolaou (1883-1962). A screening test for the prevention of cancer of uterine cervix.
    Michalas SP
    Eur J Obstet Gynecol Reprod Biol; 2000 Jun; 90(2):135-8. PubMed ID: 10825631
    [No Abstract]   [Full Text] [Related]  

  • 39. Replacing the Pap Test With Screening Based on Human Papillomavirus Assays.
    Massad LS
    JAMA; 2018 Jul; 320(1):35-37. PubMed ID: 29971379
    [No Abstract]   [Full Text] [Related]  

  • 40. Cervical Cancer Screening-Moving From the Value of Evidence to the Evidence of Value.
    Sawaya GF
    JAMA Intern Med; 2018 Oct; 178(10):1293-1295. PubMed ID: 30140917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.